Thoratec Corp (NASDAQ:THOR)

39.88
Delayed Data
As of Mar 03
 -0.37 / -0.92%
Today’s Change
22.50
Today|||52-Week Range
41.26
+22.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$2.2B

Company Description

Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag and PediMag/PediVAS product lines. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA.

Contact Information

Thoratec Corp.
6035 Stoneridge Drive
Pleasanton California 94588
P:(925) 847-8600
Investor Relations:
(925) 738-0029

Employees

Shareholders

Mutual fund holders52.13%
Other institutional43.15%
Individual stakeholders22.63%

Top Executives

D. Keith GrossmanPresident, Chief Executive Officer & Director
Taylor C. HarrisChief Financial Officer & Vice President
David A. LehmanSecretary, Senior Vice President & General Counsel
Vasant PadmanabhanSenior Vice President-Technical Operations
Niamh Louise PellegriniPresident-North American Operations

To view my watchlist

Not a member yet?

Sign up now for a free account